Covaxin found to neutralise 617 variant of COVID-19, says Dr. Fauci
The Hindu
Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, trial results have showed that Covaxin has an efficacy of 78%.
Covaxin, India’s home-grown vaccine, has been found to neutralise the 617 variant of the deadly virus, White House chief medical adviser and America’s top pandemic expert Dr. Anthony Fauci said here. Dr. Fauci was speaking to reporters during a conference call on Tuesday. “This is something where we’re still gaining data on a daily basis. But the most recent data, was looking at convalescent Sera of COVID-19 cases and people who received the vaccine used in India, the Covaxin. It was found to neutralise the 617 variants,” he said.More Related News